Check List
Which checklist fits which study design
Reporting guidelines are written for a design, not a discipline. The quickest way to choose is to name what you actually did, then match it below. Where a study combines designs, the primary design governs and the secondary one is covered by an extension or a companion checklist.
| What you are reporting | Checklist on this page |
|---|---|
| Two-group parallel randomised trial | CONSORT 2010 (check whether your journal now asks for CONSORT 2025) |
| Trial protocol | SPIRIT 2025 |
| Cohort, case-control or cross-sectional study | STROBE, with the design-specific version |
| Systematic review, with or without meta-analysis | PRISMA 2020; MOOSE where the pooled studies are observational |
| Diagnostic accuracy study | STARD 2015 |
| Interviews, focus groups or other qualitative work | COREQ or SRQR |
| Single patient case | CARE |
| Cost-effectiveness or other economic evaluation | CHEERS 2022 |
| Quality improvement project | SQUIRE 2.0, or EBPQI for nursing evidence-based practice work |
| In vivo animal experiment | ARRIVE 2.0 |
| Oncology real-world evidence | ESMO-GROW |
| Trial altered by an extenuating event such as a pandemic | CONSERVE 2021 |
TIDieR is not a stand-alone choice: it sits alongside CONSORT, SPIRIT or STROBE whenever an intervention needs to be described well enough to be repeated.
Reporting guidelines are not appraisal tools
Most items on this page tell an author what to report. A completed CONSORT or STROBE checklist shows that the information is present; it says nothing about whether the randomisation was sound or the confounders were well chosen. Two entries work differently. AGREE II is an appraisal instrument for clinical practice guidelines, scored by assessors across six domains, and the Cochrane dissemination checklist concerns how review findings are communicated to non-specialist readers. Using an appraisal tool as if it were a reporting checklist, or the reverse, is a common source of confused methods sections.
Opening the checklist at the right point in a project
- Planning. Read the guideline before data collection. Items such as sample-size justification, pre-specified outcomes and allocation concealment cannot be reported if they were never recorded.
- Drafting. Write each Methods paragraph with the relevant items open, and note the page or line where each is met.
- Submission. Many journals require the completed checklist as a supplementary file. Use the version the journal names in its author instructions, and mark items that genuinely do not apply as such rather than leaving them blank.
- Revision. Reviewers frequently cite checklist items by number. Update the page references after every round, because moved text makes an old checklist misleading.
Versions and extensions that change the answer
Several of these guidelines have been revised recently or have design-specific extensions: CONSORT has extensions for cluster, non-inferiority and pragmatic trials; PRISMA has PRISMA-P for protocols and PRISMA-ScR for scoping reviews. The EQUATOR Network library lists the current version of each guideline and its extensions, and is the reference to check when a journal and a checklist page disagree. For a final pass before upload, our pre-submission peer review checks the manuscript against the checklist the target journal specifies.
Common questions
Do I need a reporting checklist if the journal does not ask for one?
It is still worth completing. Reviewers and editors use the same guidelines informally when judging whether a methods section is complete, and many reviewer requests for clarification map directly onto checklist items. Completing it before submission catches missing information while it can still be retrieved from study records, rather than during revision when it may no longer be available.
My study uses more than one design. Which checklist should I use?
Report against the guideline for the primary design and add the items that matter from the secondary one, or use a published extension if one exists. A trial with an embedded qualitative component, for example, would follow CONSORT for the trial and draw on COREQ or SRQR for the qualitative work, stating clearly in the methods which guidance governed each part.
























